PREOPERATIVE EXTENDED CHEMOTHERAPY VS. CHEMOTHERAPY PLUS HYPOFRACTIONATED RADIATION THERAPY FOR BORDERLINE RESECTABLE ADENOCARCINOMA OF THE HEAD OF THE PANCREAS

Protocol: 
AAAR3715
Phase: 
II

PREOPERATIVE EXTENDED CHEMOTHERAPY VS. CHEMOTHERAPY PLUS HYPOFRACTIONATED RADIATION THERAPY FOR BORDERLINE RESECTABLE ADENOCARCINOMA OF THE HEAD OF THE PANCREAS

Are you Eligible? (Inclusion Criteria)

1. Age ≥ 18 years
2. No prior chemotherapy or radiation for pancreatic cancer and no definitive
resection of pancreatic cancer.
3. ECOG Performance Status 0 or 1
4. Not pregnant and not nursing - For women of childbearing potential only, a
negative pregnancy test done less than 7 days prior to registration is
required.

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States